BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32782565)

  • 1. Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002.
    Diotaiuti S; De Summa S; Altieri R; Dantona C; Tommasi S; Di Gennaro M; Rubini G; Pastena MI; Argentiero A; Zito FA; Silvestris N; Paradiso AV
    Oncol Lett; 2020 Sep; 20(3):2469-2476. PubMed ID: 32782565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
    Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
    Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
    Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.
    Okamoto T; Yamazaki K; Kanbe M; Kodama H; Omi Y; Kawamata A; Suzuki R; Igari Y; Tanaka R; Iihara M; Ito Y; Sawada T; Nishikawa T; Maki M; Kusakabe K; Mitsuhashi N; Obara T
    Breast Cancer; 2005; 12(3):203-10. PubMed ID: 16110290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
    Schwartz GF
    Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
    Ong CT; Thomas SM; Blitzblau RC; Fayanju OM; Park TS; Plichta JK; Rosenberger LH; Hyslop T; Shelley Hwang E; Greenup RA
    Ann Surg Oncol; 2017 Nov; 24(12):3559-3566. PubMed ID: 28879416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Probability of Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Metastasis using Two Different Methods.
    Başoğlu İ; Çelik MF; Dural AC; Ünsal MG; Akarsu C; Baytekin HF; Kapan S; Alış H
    J Breast Health; 2015 Oct; 11(4):172-179. PubMed ID: 28331717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Sentinel Lymph Node Biopsy Status in Breast Cancers with PET/CT Negative Axilla.
    Chinnappan S; Chandra P; Kumar S; Sridev MB; Jain D; Chandran G; Nath S
    World J Nucl Med; 2022 Jun; 21(2):120-126. PubMed ID: 35865159
    [No Abstract]   [Full Text] [Related]  

  • 17. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.
    Rebollo-Aguirre AC; Gallego-Peinado M; Sánchez-Sánchez R; Pastor-Pons E; García-García J; Chamorro-Santos CE; Menjón-Beltrán S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):240-5. PubMed ID: 23684711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Ultrasound-guided Core Biopsy of Axillary Nodes for Staging of Clinically Negative Axilla in Breast Cancer Patients - A Pilot Study.
    Afzal S; Masroor I; Munir A; Idress R; Khan P; Khan S
    Cureus; 2020 Jan; 12(1):e6718. PubMed ID: 32104639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Lymph Node Burden in Invasive Breast Cancer: A Comparison of the Predictive Value of Ultrasound-Guided Needle Biopsy and Sentinel Lymph Node Biopsy.
    Boone BA; Huynh C; Spangler ML; Sumkin J; Johnson R; McGuire KP; Soran A; Ahrendt GM
    Clin Breast Cancer; 2015 Oct; 15(5):e243-8. PubMed ID: 25922244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.